72.30
price down icon0.47%   -0.34
pre-market  Pre-mercato:  72.12   -0.18   -0.25%
loading
Precedente Chiudi:
$72.64
Aprire:
$73.03
Volume 24 ore:
1.60M
Relative Volume:
0.79
Capitalizzazione di mercato:
$12.67B
Reddito:
$342.96M
Utile/perdita netta:
$-864.29M
Rapporto P/E:
-13.03
EPS:
-5.55
Flusso di cassa netto:
$-636.03M
1 W Prestazione:
+3.75%
1M Prestazione:
-1.55%
6M Prestazione:
+5.83%
1 anno Prestazione:
+181.76%
Intervallo 1D:
Value
$71.95
$73.39
Intervallo di 1 settimana:
Value
$69.18
$73.39
Portata 52W:
Value
$21.92
$84.91

Insmed Inc Stock (INSM) Company Profile

Name
Nome
Insmed Inc
Name
Telefono
908-977-9900
Name
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Dipendente
1,271
Name
Cinguettio
@insmed
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
INSM's Discussions on Twitter

Confronta INSM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INSM
Insmed Inc
72.30 12.67B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-25 Iniziato RBC Capital Mkts Outperform
2024-04-23 Iniziato Truist Buy
2024-02-15 Iniziato Wolfe Research Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-11-20 Ripresa JP Morgan Overweight
2023-07-26 Iniziato Guggenheim Buy
2022-12-09 Iniziato Mizuho Buy
2022-12-07 Iniziato Barclays Overweight
2022-11-18 Iniziato BofA Securities Buy
2022-04-27 Iniziato Goldman Buy
2021-12-06 Iniziato JP Morgan Overweight
2021-10-19 Ripresa Monness Crespi & Hardt Buy
2021-10-19 Ripresa Morgan Stanley Overweight
2021-10-08 Iniziato Cantor Fitzgerald Overweight
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-17 Iniziato Berenberg Buy
2020-10-12 Ripresa Stifel Buy
2019-09-03 Iniziato Goldman Buy
2019-04-09 Reiterato H.C. Wainwright Buy
2019-02-15 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Aggiornamento Goldman Neutral → Buy
2019-01-02 Iniziato Canaccord Genuity Buy
2018-08-06 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Iniziato Goldman Neutral
2018-04-23 Aggiornamento Credit Suisse Neutral → Outperform
2018-03-21 Iniziato Morgan Stanley Overweight
2018-01-18 Iniziato Credit Suisse Neutral
2017-09-05 Reiterato Evercore ISI Outperform
2017-08-17 Iniziato Evercore ISI Outperform
2017-07-11 Iniziato Robert W. Baird Outperform
2016-03-15 Iniziato Stifel Buy
2015-11-09 Downgrade UBS Buy → Neutral
2015-10-06 Reiterato H.C. Wainwright Buy
2015-06-09 Iniziato Citigroup Neutral
2014-03-26 Reiterato HC Wainwright Buy
Mostra tutto

Insmed Inc Borsa (INSM) Ultime notizie

pulisher
May 04, 2025

Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy - Insider Monkey

May 04, 2025
pulisher
May 01, 2025

Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

Insmed Incorporated (INSM): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside Potential - Insider Monkey

Apr 30, 2025
pulisher
Apr 29, 2025

Insmed To Present at the BofA Securities 2025 Health Care Conference - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Insmed To Present at the BofA Securities 2025 Health Care Conference | INSM Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Insmed Inc (INSM)’s Day in Review: Closing at 69.69, Up by 1.06 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Gaining Ground: Insmed Inc (INSM) Closes Lower at 72.00, Down -5.62 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Top Medical Stocks To Watch Now – April 25th - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Insmed Inc [INSM] moved down -2.60: Why It’s Important - dbtnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Could investigational drug become first-in-class bronchiectasis therapy? - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

Insmed: Poised For Transformation Beyond ARIKAYCE (NASDAQ:INSM) - Seeking Alpha

Apr 25, 2025
pulisher
Apr 25, 2025

Insmed Inc [INSM] stock for 479,177 USD was sold by Lewis William - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Insmed’s (INSM) Buy Rating Reiterated at HC Wainwright - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Insmed Sees Unusually Large Options Volume (NASDAQ:INSM) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Insmed Inc (INSM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed Calls In Convertible Notes, Proposes Share Conversion - Finimize

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed to redeem $569.5 million convertible notes due 2028 By Investing.com - Investing.com Canada

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed Inc (NASDAQ:INSM) Rises 5.71% In 2025; Is It Still Attractive At $70.85? - Marketing Sentinel

Apr 24, 2025
pulisher
Apr 24, 2025

INSM’s price-to-sales ratio: A comparative analysis with its peers - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed to Redeem $569.5 Million of Convertible Senior Notes - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed Announces Redemption of all $569.5 Million of Remaining O - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Insmed Flexes Financial Muscle with $569M Early Note Redemption: What it Means for Investors - Stock Titan

Apr 24, 2025
pulisher
Apr 23, 2025

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Insmed (INSM) Reports Promising Phase 3 Results for Brensocatib - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis | INSM Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Insmed (INSM) Reports Promising Phase 3 Results for Brensocatib in Treating Bronchiectasis | INSM Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Insmed to Host First-Quarter 2025 Financial Results Conference C - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 | INSM Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Insmed Q1 2025 Earnings Preview: What New Financial Metrics Will Shape Growth Strategy? - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

H.C. Wainwright maintains Buy on Insmed stock with $90 target By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 18, 2025

Cerity Partners LLC Sells 3,090 Shares of Insmed Incorporated (NASDAQ:INSM) - American Banking and Market News

Apr 18, 2025
pulisher
Apr 17, 2025

Insmed Incorporated (NASDAQ:INSM) Given Average Recommendation of “Buy” by Analysts - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Insmed CEO William Lewis sells $479,176 in stock By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 16, 2025

Insmed CEO William Lewis sells $479,176 in stock - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

New cathepsin C inhibitors disclosed in Insmed patent - BioWorld MedTech

Apr 16, 2025
pulisher
Apr 16, 2025

Envestnet Asset Management Inc. Buys 15,227 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 16, 2025
pulisher
Apr 16, 2025

Wells Fargo & Company MN Buys 33,214 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - MarketScreener

Apr 15, 2025
pulisher
Apr 15, 2025

Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

LPL Financial LLC Raises Position in Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Commit To Purchase Insmed At $50, Earn 13.9% Annualized Using Options - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

Cantor Fitzgerald maintains Overweight on Insmed stock, bullish on TPIP By Investing.com - Investing.com Canada

Apr 11, 2025
pulisher
Apr 11, 2025

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Community Health (CYH) and Argenx Se (ARGX) - The Globe and Mail

Apr 11, 2025
pulisher
Apr 08, 2025

Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

10 Best Long Term Growth Stocks to Buy According to Billionaires - Insider Monkey

Apr 08, 2025
pulisher
Apr 04, 2025

Form DEF 14A INSMED Inc For: May 15 - StreetInsider

Apr 04, 2025
pulisher
Apr 04, 2025

Insmed CEO William Lewis sells $502,577 in stock By Investing.com - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock - Investing.com Australia

Apr 03, 2025

Insmed Inc Azioni (INSM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Insmed Inc Azioni (INSM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Lewis William
Chair and CEO
May 01 '25
Sale
72.57
6,830
495,668
233,924
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
Capitalizzazione:     |  Volume (24 ore):